Matthew J Shepard1,2, Ali S Haider1, Sujit S Prabhu1,3, Raymond Sawaya1,3, Franco DeMonte1,3, Ian E McCutcheon1,3, Jeffrey S Weinberg1,3, Sherise D Ferguson1,3, Dima Suki1,3, Gregory N Fuller4,3, Frederick F Lang5,6. 1. Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. 2. Department of Neurosurgery, Allegheny Health Network, Pittsburgh, PA, USA. 3. Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. 4. Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. 5. Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. flang@mdanderson.org. 6. Brain Tumor Center, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. flang@mdanderson.org.
Abstract
PURPOSE: Pineal region tumors are surgically demanding tumors to resect. Long term neuro-oncologic outcomes following surgical excision of tumors from this region have been underreported. We sought to define the long term outcomes of patients undergoing resection of pineal region tumors. METHODS: A retrospective analysis of a prospectively maintained database was performed on patients who underwent intended surgical excision of pineal region tumors. Overall survival (OS) and progression free survival (PFS) were the primary endpoints of this study. Factors associated with OS, PFS and the degree of resection were analyzed, along with 30-day complication rates and dependence on CSF diversion. RESULTS: Sixty-eight patients with a mean age of 30.9 ± 15.3 years were analyzed. The median clinical and radiographic follow-up was 95.7 and 48.2 months, respectively. The supracerebellar infratentorial and the occipital transtentorial corridors were utilized in the majority of cases (80.9%). The gross total resection (GTR) rate was 52.9% (n=36). The 5-year OS and PFS rates were 70.2% and 58.5%, respectively. Achieving GTR was associated with improved OS (HR 0.39, p = 0.03) and PFS (HR 0.4, p = 0.006). The 30-day mortality rate was 5.9%. The need for CSF diversion was high with 77.9% of patients requiring a shunt or ETV by last follow-up. CONCLUSIONS: This is the first modern surgical series providing long term follow-up for patients undergoing surgical resection of pineal region tumors. Obtaining a GTR of these challenging tumors is beneficial with regards to PFS/OS. Higher grade tumors have diminished PFS/OS and are treated with adjuvant chemotherapy and/or radiotherapy.
PURPOSE: Pineal region tumors are surgically demanding tumors to resect. Long term neuro-oncologic outcomes following surgical excision of tumors from this region have been underreported. We sought to define the long term outcomes of patients undergoing resection of pineal region tumors. METHODS: A retrospective analysis of a prospectively maintained database was performed on patients who underwent intended surgical excision of pineal region tumors. Overall survival (OS) and progression free survival (PFS) were the primary endpoints of this study. Factors associated with OS, PFS and the degree of resection were analyzed, along with 30-day complication rates and dependence on CSF diversion. RESULTS: Sixty-eight patients with a mean age of 30.9 ± 15.3 years were analyzed. The median clinical and radiographic follow-up was 95.7 and 48.2 months, respectively. The supracerebellar infratentorial and the occipital transtentorial corridors were utilized in the majority of cases (80.9%). The gross total resection (GTR) rate was 52.9% (n=36). The 5-year OS and PFS rates were 70.2% and 58.5%, respectively. Achieving GTR was associated with improved OS (HR 0.39, p = 0.03) and PFS (HR 0.4, p = 0.006). The 30-day mortality rate was 5.9%. The need for CSF diversion was high with 77.9% of patients requiring a shunt or ETV by last follow-up. CONCLUSIONS: This is the first modern surgical series providing long term follow-up for patients undergoing surgical resection of pineal region tumors. Obtaining a GTR of these challenging tumors is beneficial with regards to PFS/OS. Higher grade tumors have diminished PFS/OS and are treated with adjuvant chemotherapy and/or radiotherapy.
Authors: Juha Hernesniemi; Rossana Romani; Baki S Albayrak; Hanna Lehto; Reza Dashti; Christian Ramsey; Ayse Karatas; Andrea Cardia; Ondrej Navratil; Anna Piippo; Minoru Fujiki; Stefano Toninelli; Mika Niemelä Journal: Surg Neurol Date: 2008-12
Authors: Noor Malik; Derek C Samples; Megan M Finneran; Sarah Graber; Kathleen Dorris; Gregory Norris; Nicholas K Foreman; Todd C Hankinson; Michael H Handler Journal: Childs Nerv Syst Date: 2022-07-14 Impact factor: 1.532
Authors: Ehab Shabo; Thomas Czech; James C Nicholson; Conor Mallucci; Carmine Mottolese; Gianluca Piatelli; Didier Frappaz; Matthew Jonathan Murray; Cecile Faure-Conter; Maria Luisa Garrè; Sevgi Sarikaya-Seiwert; Leonie Weinhold; Hannes Haberl; Gabriele Calaminus Journal: Cancers (Basel) Date: 2022-07-21 Impact factor: 6.575